Correlation Between GlucoTrack and Heartbeam Warrant

Can any of the company-specific risk be diversified away by investing in both GlucoTrack and Heartbeam Warrant at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlucoTrack and Heartbeam Warrant into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GlucoTrack and Heartbeam Warrant, you can compare the effects of market volatilities on GlucoTrack and Heartbeam Warrant and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlucoTrack with a short position of Heartbeam Warrant. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlucoTrack and Heartbeam Warrant.

Diversification Opportunities for GlucoTrack and Heartbeam Warrant

-0.82

Correlation Coefficient

GlucoTrack  Heartbeam Warrant

Pay attention - limited upside

The 3 months correlation between GlucoTrack and Heartbeam is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding GlucoTrack and Heartbeam Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heartbeam Warrant and GlucoTrack is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlucoTrack are associated (or correlated) with Heartbeam Warrant. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heartbeam Warrant has no effect on the direction of GlucoTrack i.e., GlucoTrack and Heartbeam Warrant go up and down completely randomly.

Pair Corralation between GlucoTrack and Heartbeam Warrant

Given the investment horizon of 90 days GlucoTrack is expected to under-perform the Heartbeam Warrant. But the stock apears to be less risky and, when comparing its historical volatility, GlucoTrack is 1.4 times less risky than Heartbeam Warrant. The stock trades about -0.06 of its potential returns per unit of risk. The Heartbeam Warrant is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  70.00  in Heartbeam Warrant on September 19, 2024 and sell it today you would earn a total of  12.00  from holding Heartbeam Warrant or generate 17.14% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

GlucoTrack  vs.  Heartbeam Warrant

GlucoTrack

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GlucoTrack has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Heartbeam Warrant

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Heartbeam Warrant are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Heartbeam Warrant showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with GlucoTrack and Heartbeam Warrant

The main advantage of trading using opposite GlucoTrack and Heartbeam Warrant positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlucoTrack position performs unexpectedly, Heartbeam Warrant can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heartbeam Warrant will offset losses from the drop in Heartbeam Warrant's long position.

The idea behind GlucoTrack and Heartbeam Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.